IAS 2025, the 13th IAS Conference on HIV Science - Kigali, Rwanda, July 13-17, 2025 2025 Conference on Retroviruses and Opportunistic Infections (CROI) - San Francisco, CA, March 9-12, 2025 2025 Pre-CROI Community HIV Cure Research Workshop - San Francisco,…
Treatment Action Group mourns the death of TAG’s founding treasurer Marvin Shulman (May 17, 1932–January 15, 2014), who died Wednesday in Miami Beach, Florida.
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
Treatment Action Group applauds the donors who have helped make it possible to save more lives by raising a record-breaking $12 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria over the next three years. TAG also commends the Obama administration for its generous match of one dollar for every two dollars contributed by other donors, which helped to drive up funding commitments in the current replenishment round.
Since the introduction of highly active antiretroviral therapy (ART) in 1996, the annual death rate from HIV/AIDS has dropped in the United States by over two-thirds. The U.S. Centers for Disease Control and Prevention estimates that approximately 1.2 million Americans are living with HIV.
Today, on World AIDS Day, amfAR, The Foundation for AIDS Research, and Treatment Action Group (TAG) called for a deliberate and expedited research agenda designed to begin to end the AIDS epidemic in the United States. Both organizations noted that in order to achieve this goal, Congress must end sequestration and work to ensure the full implementation of the Affordable Care Act (ACA).
167 Organizations and 513 Individuals Signed on to Letter to Secretary Sebelius on the Allowance of Co-pay Assistance in the ACA Health Plans
November 2013 By Karyn Kaplan and Tracy Swan The purpose of this manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment…
The science of discovery comes with ethical challenges in human clinical trials By Richard Jefferys Over the past several years, there has been a welcome invigoration of the research effort to cure HIV infection. The mainstream media has picked up…